Stereotactic Body Radiation May be a Treatment Option for Unresectable Recurrent Head and Neck Cancers

Results of the study found that administering stereotactic body radiation therapy with concurrent Cisplatin is a well-tolerated and feasible...

The World’s First T-cell Therapy for a Solid Tumor Cancer is Poised for Approval via Moffitt Partnership (1)

Iovance’s investment is further proof that the Cellular Immunotherapy Program at Moffitt is a leading center for cell and gene therapy research

Veliparib Monotherapy Study Suggests Benefits for Advanced HER2 Negative Breast Cancer Patients

Veliparib may be a suitable treatment following the use of combination chemotherapy for a limited duration.

Novel Role of Specific Histone Deacetylase in Non-Small Cell Lung Cancer Discovered

Moffitt researchers conducted a series of preclinical studies to investigate the role of HDAC11 in NSCLC. They discovered that high levels of HDAC11...

Collaboration on New Developments for Robotic Lung Surgery Computer Interface

Dr. Jacques Fontaine and Dr. Eric Toloza are collaborating with researchers and engineers who are developing the computer interface enhancements for...

Moffitt’s Molecular Biology Lab Creates Own COVID-19 Diagnostic Test

As cases of COVID-19 increased in our community, so did the need for testing. Moffitt’s pathology department joined forces with the Moffitt...

Virtual Oncology Visits Are Up 5,000% at Moffitt— Are They Here to Stay After COVID-19?

Since the pandemic began, Moffitt’s telehealth services expanded to include new patient visits and those in need of a second opinion

Moffitt’s HPV Research Impacts Practice and Policy Worldwide

When people hear the phrase cancer research, they usually think about cutting-edge immunotherapies, clinical trials or lab work using cells and...

Grand Opening of New Moffitt Clinic Dedicated to Immune Cell Therapy

The new clinic will focus on cellular immunotherapies such as chimeric antigen receptor T-cell therapy (CAR T), which reengineers a patient’s own...

Novel Drug Delivery Tool Enhances Treatment of Recurrent Glioblastoma

Convection enhanced delivery (CED) involves the placement of one or more catheters into brain tumors and tumor-infiltrated brain in order to slowly...

Innovative 3D Visualization Technology Enhances Brain Cancer Treatment

The Neuro-Oncology Program is using a novel 3D surgical exoscope called the Orbeye. This technology uses a dye called 5-Aminolevulinic Acid, or...

Moffitt Researchers Utilize the Genomic-Adjusted Radiation Dose to Personalize Radiotherapy in Cancer Care

Utilizing the linear quadratic model and the radiosensitivity index (RSI), we have derived an expression for the genomically adjusted radiation dose...